MOR MorphoSys AG Net earnings per share growth this year
Cold chain optimization for biocomponent supplies guarantees MorphoSys AG operational resilience. Annual variable EPS demonstrates how ownership of exclusive antibody patents allows the company to maintain premium pricing power, with the metric currently standing at -10.10. The impeccable status of the German biotech firm was definitively confirmed following a strategic merger with a leading Swiss pharma holding, providing full market validation of its assets.
Financial and market metric breakdowns for MorphoSys AG (MOR)
- stock value and consensus price forecast:
- market capitalization data:
- company book value details:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
MOR - Company Net Income|Company Profit Forecast MorphoSys AG|MOR - Price to Earnings Ratio|Future Price to Earnings Multiple MorphoSys Corporation|MOR - PEG Multiple|EV/EBITDA Multiple MorphoSys Corporation|MOR - Operating profit EBITDA|Net earnings per share for the trailing year MorphoSys|MOR - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months morphosys.com|MOR - Earnings per share growth in current year|Expected net earnings per share growth next year MorphoSys AG
Basic company analysis:MOR MorphoSys Inc
This indicator determines the dynamics of net earnings per share, separating real business value growth from market volatility. Negative values or a decline in growth rates signal stagnation in fundamental metrics. By analyzing the annual EPS change, an investor can see the efficiency of royalties from oncology drug sales and the success of MorphoSys AG (MOR) strategic partnerships with pharmaceutical behemoths.
Main competitors
Earnings per share growth rate in current year BeiGene Ltd. (ONC)|Earnings per share growth in current year Halozyme Inc.|Net earnings per share growth this year Revolution Medicines Corp (RVMD)|Earnings per share growth in current year Ascentage Pharma Group (AAPG)|CGON - Earnings per share growth rate in current year|Earnings per share growth in current year UroGen Pharma URGN|Earnings per share increase in current year BCAX|PSNL - Earnings per share growth in current year|Earnings per share trend in current year ERAS|DCTH: Earnings growth in current year|ymabs.com - Earnings per share increase in current year|Earnings per share growth in current year Aura Biosciences|Earnings per share growth rate in current year Candel CADL|Earnings per share growth in current year Accuray Inc. (ARAY)|Expected net earnings per share growth this year sellaslifesciences.com|Actuate Therapeutics, Inc. - Net earnings per share growth this year|citiusonc.com (CTOR) - Earnings per share growth rate in current year|HURA - Earnings per share growth in current year|Expected net earnings per share growth this year Protara Therapeutics Inc TARA|FATE (Fate Therapeutics Corp) - Net earnings per share growth this year|Aadi Bioscience - Earnings per share increase in current year|TCRX (TScan Therapeutics Inc) - Earnings growth in current year|Earnings growth in current year Champions Oncology Corp|Earnings growth in current year XBIT|cel-sci.com (CVM) - Net earnings per share change in current year|Earnings per share growth in current year OS Therapies Inc OSTX|RADX - Net earnings per share growth this year|ARTV - Earnings per share growth in current year|Earnings per share growth rate in current year Adlai Nortye Ltd.|Veru (VERU) - Earnings per share growth in current year|Tempest Therapeutics Inc - Earnings per share increase in current year|XLO (Xilio Therapeutics Inc) - Earnings growth in current year|Net earnings per share growth this year Enochian BioSciences (RENB)|Earnings growth in current year MURA|Earnings growth in current year kairospharma.com (KAPA)|Earnings per share growth in current year OnKure Therapeutics OKUR|GDTC: Earnings per share growth this year|Curis Corp - Earnings growth in current year|Apollomics, Inc. (APLM) - Net earnings per share growth this year|THAR: Earnings growth in current year|Earnings per share growth rate in current year Advanced Biomed (ADVB)|Earnings per share growth in current year Genprex|CLDI: Earnings per share increase in current year|Net earnings per share growth this year SBFM (Sunshine Biopharma, Inc.)|XBIO (xeneticbio.com) - Earnings per share increase in current year|Earnings growth in current year SLRX (Salarius Pharmaceuticals)|PPBT - Net earnings per share growth this year|AONC: Net earnings per share growth this year|BGNE - Earnings growth in current year|Checkpoint Therapeutics, Inc (CKPT) - Earnings per share growth in current year|elevationoncology.com - Earnings per share increase in current year|ICAD (iCAD Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Ikena IKNA|Earnings per share growth in current year Notable Labs (NTBL)|Net earnings per share growth this year viracta.com VIRX|Earnings per share growth in current year NAYA Bio NAYA|Ascentage (AAPGV) - Earnings per share growth rate in current year
